Current issues with influenza vaccination in egg allergy

Journal of Allergy and Clinical Immunology

Volumn 110, Issue 6, 2002, Pages 834-840

  Zeiger, Robert S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Asthma; Egg allergy; Influenza vaccination

Indexed keywords

EGG PROTEIN; INFLUENZA VACCINE;

ASTHMA; EGG ALLERGY; HIGH RISK POPULATION; HUMAN; INFLUENZA VACCINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN CONTENT; REVIEW; SAFETY; SKIN TEST;

EID: 0036916391     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2002.129372     Document Type: Review

References (64)

1. CDC. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2002:51:1-31. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5103al.htm.
2. Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001:344:889-96.
3. Ratner B, Untracht S. Allergy to virus and rickettsial vaccines. I. Allergy to influenza A and B vaccine in children. JAMA 1946;132:899-905.
4. Bierman CW, Shapiro GG, Pierson WE, Taylor JW, Foy HM, Fox JP. Safety of influenza vaccination in allergic children. J Infect Dis 1977;136:S652-5.
5. Miller JR, Orgel HA, Meltzer EO. The safety of egg-containing vaccines for egg-allergy patients. J Allergy Clin Immunol 1983;71:568-73.
6. Murphy KR, Strunk RC. Safe administration of influenza vaccine in asthmatic children hypersensitive to egg protein. J Pediatr 1985;106:931-3.
7. James JM, Zeiger RS, Lestor MR, et al. Safe administration of influenza vaccine to patients with egg allergy. J Pediatr 1998;133:624-8.
8. Glezen WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 1982;4:25-44.
9. Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Cough RB. Impact of respiratory virus infection on persons with underlying conditions. JAMA 2000;283:499-505.
10. Neuzil KM, Wright PF, Mitchel EF, Griffin MR. The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr 2000:137:856-64.
11. Kondo S. Abe K. The effects of influenza virus infection on FEV I in asthmatic children: The time course study. Chest 1991;100:1235-8.
12. Pickering LK, editor. 2000 Red Book: Report of the Committee on Infectious Diseases. 25th Ed. Elk Grove Village (IL): American Academy of Pediatrics Publications: 2000. p. 36, 358.
13. National Institutes of Health and National Heart, Lung, and Blood Institute. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Bethesda: National Institutes of Health: 1997. NIH publication no. 97-4051.
14. Chung EK, Casey R, Pinto-Martin JA, Pawlowski NA, Bell LM. Routine and influenza vaccination rates in children with asthma. Ann Allergy Asthma Immunol 1998:80:318-22.
15. Kramarz P, DeStefano F, Gargiullo PM, et al. Does influenza vaccination prevent asthma exacerbations in children? J Pediatr 2001;138:306-10.
16. Nicholson KG, Nguyen-Van-Tam JS, Ahmed AH, et al. Randomized placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma. Lancet 1998;351:326-31.
17. The American Lung Association Asthma Clinical Research Centers. The safety of inactivated influenza vaccine in adults and children with asthma. N Engl J Med 2001;345:1529-36.
18. Reid DW, Bromly CL, Stenton SC, Hendrick DJ, Bourke SJ. A double-blind placebo-controlled study of the effect of influenza vaccination on airway responsiveness in asthma. Respir Med 1998;92:1010-1.
19. Sener M, Gursel G, Turktas H. Effects of inactivated influenza virus vaccination on bronchial reactivity, symptom scores, and peak expiratory flow variability in patients with asthma. J Asthma 1999:36:165-9.
20. Stenius-Aarniala B, Huttunen JK, Pyhala R, et al. Lack of clinical exacerbations in adults with chronic asthma after immunization with killed influenza virus. Chest 1986;89:786-9.
21. Cates C, Jefferson T, Bara A. Influenza Vaccination in Asthma: Efficacy and Side-Effects (Cochrane Review): The Cochrane Library. Oxford, England: Update Software, 1999. Available at: www.update-software.com/cochrane.
22. Atmar RL, Bloom K, Keitel W, Couch R, Greenberg SB. Effect of live attenuated, cold recombinant (CR) influenza virus vaccines on pulmonary function in healthy and asthmatic children. Vaccine 1990;8:217-24.
23. Park CL, Frank AL, Sullivan M, Jindal P, Baxter BD. Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy. Pediatrics 1996;98:196-200.
24. Fairchok MP, Trementozzi DP, Carter PS, Regnery HL, Carter ER. Effect of prednisone on response to influenza virus vaccine in asthmatic children. Arch Pediatr Adolesc Med 1998;152:1191-5.
25. Demicheli V, Rivetti D, Deeks JJ, Jefferson TO. Vaccines for Preventing Influenza in Healthy Adults (Cochrane Review). The Cochrane Library. Oxford, England: Update Software: 1999. Available at: www.update-software.com/cochrane.
26. Poole PJ, Chacko E, Wood-Baker RWB, Cates CJ. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Airways Group Cochrane Database of Systematic Reviews 2002.
27. Bell TD, Chai H, Berlow B, Daniels G. Immunization with killed influenza virus in children with chronic asthma. Chest 1978;73:140-5.
28. Smits AJ, Hak E, Stalman WA, van Essen GA, Hoes AW, Verheij TJ. Clinical effectiveness of conventional influenza vaccination in asthmatic children. Epidemiol Infect 2002;128:205-11.
29. Neuzil KM, Influenza vaccine in children with asthma: Why no progress? J Pediatr 2001;138:301-3.
30. O'Brien TC, Maloney C, Tauraso NM. Quantitation of residual host protein in chicken embryo-derived vaccines by radial immunodiffusion. Appl Microbiol 1971;21:780-2.
31. Davies R, Pepys J. Egg allergy, influenza vaccine, and immunoglobulin E antibody. J Allergy Clin Immunol 1976;57:373-83.
32. Ratmer B, Untracht S. Egg allergy in children: Incidence and evaluation in relation to chick-embryo-propagated vaccines. Am J Dis Child 1952;83:309-16.
33. Anolik R, Spiegel W, Posner M, Jakabovics E. Influenza vaccine testing in egg sensitive patients. Ann Allergy 1992;68:69.
34. Kanny G, Moneret-Vautrin DA, Flabbee J, Beaudouin E, Morisset M, Thevenin F. Population study of food allergy in France. J Allergy Clin Immunol 2001;108:133-40.
35. Eggesbo M, Botten G, Halvarsen R, Magnus P. The prevalence of allergy to egg: A population-based study in young children. Allergy 2001;36:403-11.
36. Sampson HA, Ho DG. Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents. J Allergy Clin Immunol 1997;100:444-51.
37. Burks AW, James JM, Hiegel A, et al. Atopic dermatitis and food hypersensitivity reactions. J Pediatr 1998;132:132-6.
38. Niggemann B, Sieflaff B, Beyer K, Binder C, Wahn U. Outcome of double-blind, placebo-controlled food challenge tests in 107 children with atopic dermatitis. Clin Exp Allergy 1999;29:91-6.
39. Sicherer SH, Morrow EH, Sampson HA. Dose-response in double-blind, placebo-controlled oral food challenges in children with atopic dermatitis. J Allergy Clin Immunol 2000;105:582-6.
40. Sampson HA. Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol 2001;107:891-6.
41. Langeland T. A clinical and immunological study of allergy to hen's egg white. 1. A clinical study of egg allergy. Clin Allergy 1983;13:371-82.
42. Hattevig G, Kjellman B, Bjorksten B. Clinical symptoms and IgE response to common food proteins and inhalants in the first 7 years of life. Clin Allergy 1987;17:571-8.
43. Onorato J, Merland N, Terral C, Michel FB, Bousquet J. Placebo-controlled double-blind food challenge in asthma. J Allergy Clin Immunol 1986;78:1139-46.
44. Novembre E, de Martino M, Vierucci A. Foods and respiratory allergy. J Allergy Clin Immunol 1988;81:1059-65.
45. Yazicioglu M, Baspinar I, Ones U, Pala O, Kiziler U. Egg and milk allergy in asthmatic children: Assessment by immulite allergy food panel, skin prick tests and double-blind placebo-controlled food challenges. Allergol Immunopathol (Madrid) 1999;27:287-93.
46. Langeland T. Allergy to hen's egg white in atopic dermatitis. Acta Derm Venereol 1985;14:109-12.
47. Mannino DM, Homa DM, Pertowski CA, Ashizawa A, Nixon LL. Johnson CA, et al. Surveillance for asthma - United States. 1960-1995. MMWR CDC Surveill Summ 1998;47:1-27.
48. Stempel DA, Carlson AM, Buchner DA. Asthma: Benchmarking for quality improvement. Ann Allergy Asthma Immunol 1997;79:517-24.
49. Norgaard A, Bindslev-Jensen C. Egg and milk allergy in adults. Diagnosis and characterization. Allergy 1992;47:503-9.
50. Atkins FM, Steinberg SS, Metcalfe DD. Evaluation of immediate adverse reactions to foods in adult patients. I. Correlation of demographic, laboratory, and prick skin test data with response to controlled clinical challenge. J Allergy Clin Immunol 1985;75:348-55.
51. Jansen JJN, Kardinaai AFM, Huijbers G, Vlieg-Boerstra BJ, Martens BPM, Ockhuizen T. Prevalence of food allergy and intolerance in the adult Dutch population. J Allergy Clin Immunol 1994;93:446-56.
52. Stuart HC, Farnham M. Acquisition and loss of hypersensitivities in early life. Am J Dis Child 1926;32:341-9.
53. Dannaeus A, Inganas M. A follow-up study of children with food allergy. Clinical course in relation to serum IgE- and IgG-antibody levels to milk, egg, and fish. Clin Allergy 1981;11:533-9.
54. Kajosaari M. Food allergy in Finnish children aged 1 to 6 years. Acta Paediatr Scand 1982;71:815-9.
55. Bock SA, Sampson HA, Atkins FM, et al. Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: A manual. J Allergy Clin Immunol 1988;82:986-97.
56. Sampson HA. Food allergy. Part 2: Diagnosis and management. J Allergy Clin Immunol 1999;103:981-9.
57. Boyano Martinez T, Garcia-Ara C, Diaz-Pena JM, Munoz FM, Garcia Sanchez G, Esteban MM. Validity of specific 1gE antibodies in children with egg allergy. Clin Exp Allergy 2001;31:1464-9.
58. Hill DJ, Hosking CS, Reyes-Benito LV. Reducing the need for food allergen challenges in young children: A comparison of in vitro with in vivo tests. Clin Exp Allergy 2001;31:1031-5
59. Retailliau HF, Curtis AC, Storr G, Caesar G, Eddins DL, Hattwick MAW. Illness after influenza vaccination reported through a nationwide surveillance system, 1976-1977. Am J Epidemiol 1980;111:270-8.
60. Stull CA. A study to determine whether chick egg yolk sac vaccines contained sufficient egg proteins to cause severe systemic reactions if given to egg sensitive individuals. J Immunol 1946;53:343-51.
61. Chaloupka I, Schuler A, Marschall M, Meier-Ewert H. Comparative analysis of six European influenza vaccines. Eur J Clin Microbiol Infect Dis 1996;15:121-7.
62. Belshe R, Mendelman PM, Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 1998;338:1405-12.
63. Luce BR, Zangwill KM, Palmer CS, et al. Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children. Pediatrics 2001;108:E24.
64. Couch RB. Prevention and treatment of influenza. N Engl J Med 2000;343:1778-87.